Sentinel Oncology

company

About

Sentinel Oncology is a drug discovery company specialising in the delivery of candidate drugs to treat diseases.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
£193K
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

Sentinel Oncology was founded in 2005 in Cambridge, UK and is a drug discovery company dedicated to the development and commercialisation of new therapeutics to treat cancer patients for whom there is currently an unmet medical need. The Sentinel Oncology portfolio includes two programmes progressing towards IND. We are further developing a novel approach, “Targeted Synergy” that is designed to enhance therapeutic index by delivering the effects of drugs directly to the tumour.

Sentinel oncology is a fully integrated drug discovery company seeking to develop high quality drug candidates for partnering with the biotechnology and pharmaceutical industry. Our strategy relies on seeking partners and collaborators to maximise the value of our programmes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£267K
Sentinel Oncology has raised a total of £267K in funding over 2 rounds. Their latest funding was raised on Aug 12, 2010 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 12, 2010 Grant 1 East of England Development Agency Detail
May 11, 2007 Grant £193K 1 East of England Development Agency Detail
Jan 1, 2005 Grant £74K 1 East of England Development Agency Detail

Investors

Number of Lead Investors
Number of Investors
3
1
Sentinel Oncology is funded by 1 investors. East of England Development Agency are the most recent investors.
Investor Name Lead Investor Funding Round
East of England Development Agency Yes Grant